On November 6 2023, ALPHATEC HOLDINGS ($NASDAQ:ATEC) reported its earnings results for Q3 of FY2023, showing total revenue of USD 118.3 million, a rise of 31.6% from the same period in the previous year. The company also reported a net income of USD -42.6 million in comparison to the preceding year’s -37.0 million.
GoodWhale has conducted an analysis of ALPHATEC HOLDINGS‘s wellbeing, and according to their Star Chart, the company is strong in growth and assets, and weak in profitability and dividend. After further analysis, GoodWhale classified ALPHATEC HOLDINGS as a ‘cheetah’, a type of company that achieved high revenue or earnings growth but is considered less stable due to lower profitability. This type of company may be attractive to investors looking for potentially high returns, but they should be aware of the risks of investing in a company with lower profitability and a low health score of 2/10. In the event of any crisis, the company may not be able to safely ride it out without the risk of bankruptcy. In order to have a higher chance of success, investors should research the company thoroughly and take into account the potential risks. More…
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Alphatec Holdings. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Alphatec Holdings. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Alphatec Holdings. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Alphatec Holdings are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
The company’s competitors include Titan Medical Inc, Xtant Medical Holdings Inc, and Modular Medical Inc.
– Titan Medical Inc ($TSX:TMD)
Titan Medical Inc is a medical device company that develops, manufactures and sells robotic surgical systems for use in minimally invasive surgery. The company has a market cap of 68.04M as of 2022 and a Return on Equity of -55.6%. Titan Medical Inc’s products are designed to provide surgeons with enhanced visualization, dexterity and access to the surgical site. The company’s products are used in a variety of surgical procedures, including general surgery, urology, gynecology, colorectal surgery and bariatrics.
– Xtant Medical Holdings Inc ($NYSEAM:XTNT)
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development and commercialization of regenerative medicine products and platforms for the treatment of orthopedic injuries and diseases. The company’s product portfolio includes biologic scaffolds, bone graft substitutes, and other regenerative medicine products for use in spine, hip, knee, hand, foot and extremity, and sports medicine procedures. Xtant Medical’s products are sold in over 50 countries worldwide.
Xtant Medical has a market cap of 69.28M as of 2022 and a Return on Equity of -14.12%. The company is focused on the design, development and commercialization of regenerative medicine products and platforms for the treatment of orthopedic injuries and diseases. Xtant Medical’s products are sold in over 50 countries worldwide.
Modular Medical Inc is a healthcare company that provides medical products and services. The company has a market cap of 32.74M as of 2022 and a Return on Equity of -84.42%. Modular Medical Inc’s products and services include medical devices, diagnostic products, and health services. The company operates in the United States, Europe, Asia, and Africa.
ALPHATEC HOLDINGS reported its earnings results for the third quarter of FY2023, with total revenue increasing by 31.6% year-over-year to USD 118.3 million. Net income was USD -42.6 million, which is an improvement over the previous year’s -37.0 million. This suggests that the company is continuing to grow despite the challenging economic environment.
Investors should note that ALPHATEC HOLDINGS continues to focus on enhancing its product portfolio and expanding its customer base, which could lead to greater returns in the future. Overall, this is a good sign for investors considering an investment in ALPHATEC HOLDINGS.